-
A414155-50mgInformationAlofanib (RPT835) Alofanib (RPT835) is a novel selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect with IC50 <:10 nM on FGF2-induced phoshphorylation of FRS2a in KATO III cells. It has no direct effect on
-
A414155-5mgInformationAlofanib (RPT835) Alofanib (RPT835) is a novel selective allosteric inhibitor of FGFR2 and has a dramatic inhibitory effect with IC50 <:10 nM on FGF2-induced phoshphorylation of FRS2a in KATO III cells. It has no direct effect on
-
A607540-25mgalpha-D-pentagalloylglucose.
-
A607540-5mgalpha-D-pentagalloylglucose.
-
A607545-25mgalpha-ketothiazole analogue 36.
-
A607545-5mgalpha-ketothiazole analogue 36.
-
-
-
-
-
A274619-100mgAlsterpaullone.
-
A274619-25mgAlsterpaullone.